Table 3.
Medications | Self-reported (n=participants) | Medical Record (n= participants) | % Agreement |
---|---|---|---|
Long-Term Controller Medications | |||
Inhaled corticosteroids (ICS) | 5 | 11 | 33% |
ICS/Long-acting Beta Agonists (LABA) Combinations | 11 | 15 | 73% |
Systemic steroids | 11 | 19 | 58% |
Leukotriene Antagonists | 5 | 10 | 25% |
Methylxanthines | 1 | 1 | 100% |
Quick-Relief Medications | |||
Short-acting beta agonists (SABA) | 25 | 26 | 89% |
Anti-Cholinergics | 2 | 12 | 17% |